Optimind Pharma Corp. (OMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 02/28
| 05-2024 | 02-2024 | 11-2023 | 08-2023 | 05-2023 | |
| Sales | 16 | 28 | 27 | 27 | 41 |
| Operating Expenses | 114 | 166 | 122 | 184 | 418 |
| Operating Income | -98 | -138 | -96 | -157 | -377 |
| Interest Expense | 0 | 12 | 25 | 27 | 27 |
| Other Income | 0 | -565 | 16 | 0 | 0 |
| Pre-tax Income | -98 | -715 | -104 | -183 | -404 |
| Income Tax | 0 | -9 | 0 | 0 | 0 |
| Net Income Continuous | -98 | -706 | -104 | -183 | -404 |
| Net Income | $-98 | $-706 | $-104 | $-183 | $-404 |
| EBITDA(a) | $-98 | $-703 | $-74 | $-149 | $-369 |